A breakthrough in eye care could change how cataracts are treated. Researchers at Anglia Ruskin University developed eye drops containing VP1-001, a compound that reorganizes the protein clumps causing lens clouding. This allows light to pass through again, potentially restoring clear vision without surgery.

Laboratory tests on mice prone to cataracts showed remarkable results: a single drop improved lens focusing in 61% of cases, and 46% of lenses appeared visibly clearer under the microscope. While the treatment isn’t effective for all cataract types, it offers the first strong evidence that some cataracts can be reversed at their source.

If human trials succeed, this could pave the way for non-surgical, personalized solutions for vision loss, transforming eye care for millions worldwide.